Objectives: Over the last decade, extracorporeal membrane oxygenation (ECMO) has
become a promising option for patients with severe acute respiratory distress syndrome …

Purpose To evaluate the development of an extracorporeal membrane oxygenation (ECMO)
program for the treatment of acute respiratory distress syndrome (ARDS) in adults. Methods …

Background A group of patients with severe acute respiratory distress syndrome (ARDS) is
resistant to advanced respiratory therapy. In these patients, extracorporeal membrane …

Extracorporeal membrane oxygenation (ECMO) is a rapidly evolving field that was
developed more than 40 years ago for critically ill patients with respiratory failure. Despite …

Use of extracorporeal membrane oxygenation (ECMO) to support the failing heart or lung
has gained popularity. Technological advances have improved ECMO circuits and made …

Extracorporeal membrane oxygenation (ECMO) is recommended as a treatment modality for
severe acute respiratory distress syndrome (PaO 2/FiO 2≤ 100 mm Hg with positive end …

Extracorporeal membrane oxygenation (ECMO) provides days to weeks of support for
patients with respiratory, cardiac, or combined cardiopulmonary failure. Since ECMO was …

The timing of extracorporeal membrane oxygenation (ECMO) initiation and its outcome in
the management of respiratory and cardiac failure have received considerable attention, but …

Extracorporeal membrane oxygenation (ECMO) therapy has been around since the 1970s
and has completely changed how critical care physicians view supportive therapy for certain …

Extracorporeal membrane oxygenation (ECMO) for neonatal and pediatric cardiac and/or
respiratory failure is well established, and its use for adult respiratory failure is rapidly …